Yale tests drug duo to curb binge eating and promote weight loss
NCT ID NCT03946111
Summary
This Yale University study tested whether a combination of two existing medications (naltrexone and bupropion) could help people with binge-eating disorder and obesity. The trial specifically looked at patients who didn't respond well to initial treatments, comparing the medication combination against a placebo. Researchers measured changes in binge-eating frequency, weight, and related psychological symptoms over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Yale Department of Psychiatry
New Haven, Connecticut, 06510, United States
Conditions
Explore the condition pages connected to this study.